Literature DB >> 9142788

Isolation of various genotypes of Clostridium difficile from patients and the environment in an oncology ward.

S H Cohen1, Y J Tang, J Muenzer, P H Gumerlock, J Silva.   

Abstract

The epidemiology of Clostridium difficile-associated diarrhea (CDAD) is not well defined in nonepidemic situations because precise biotyping techniques have only recently become available. Arbitrarily primed polymerase chain reaction (AP-PCR) was used to determine strain identity of C. difficile isolates recovered on our oncology ward, at an incidence rate of 0.84%. Twenty-one strains of C. difficile, which were grouped into 18 different AP-PCR types, were isolated from patients' specimens. Forty-two C. difficile isolates recovered from the environment (33 toxigenic and 9 nontoxigenic) represented 9 different AP-PCR types. The most commonly found type, a toxigenic strain accounting for 29% of the environmental isolates, was widespread throughout the ward. None of the environmental types were found among the isolates from patients. Three patients' isolates were of the same AP-PCR type, and two of these patients had occupied neighboring rooms at the same time. The diversity of C. difficile isotypes suggests that endemic nosocomial CDAD is not necessarily clonally spread.

Entities:  

Mesh:

Year:  1997        PMID: 9142788     DOI: 10.1093/clinids/24.5.889

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.

Authors:  M L Landry; J Topal; D Ferguson; D Giudetti; Y Tang
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 2.  Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement.

Authors:  Massimo Antonelli; Ignacio Martin-Loeches; George Dimopoulos; Antonio Gasbarrini; Maria Sole Vallecoccia
Journal:  Intensive Care Med       Date:  2020-01-14       Impact factor: 17.440

3.  Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA.

Authors:  G Ackermann; Y J Tang; R Kueper; P Heisig; A C Rodloff; J Silva; S H Cohen
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

4.  Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Authors:  T Norén; T Akerlund; E Bäck; L Sjöberg; I Persson; I Alriksson; L G Burman
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 5.  A clinical and epidemiological review of non-toxigenic Clostridium difficile.

Authors:  Mukil Natarajan; Seth T Walk; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2013-05-29       Impact factor: 3.331

6.  Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital.

Authors:  Bo Svenungsson; Lars G Burman; Kirsti Jalakas-Pörnull; Asa Lagergren; Johan Struwe; Thomas Akerlund
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.